FindTrial
Sign In

Questionnaire survey on use of anti- allergic ophthalmic solutions for patients with seasonal allergic conjunctivitis

Questionnaire survey on use of anti- allergic ophthalmic solutions for patients with seasonal allergic conjunctivitis - Questionnaire survey on use of anti- allergic ophthalmic solutions for patients with seasonal allergic conjunctivitis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000036118
Enrollment
1000
Registered
2019-03-12
Start date
2019-03-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seasonal allergic conjunctivitis

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects diagnosed with seasonal allergic conjunctivitis by ophthalmologist and used of anti-allergic ophthalmic solutions after the end of 2018. Subjects with seasonal allergic conjunctivitis such as eye itch after the end of 2018.

Exclusion criteria

Exclusion criteria: Medical staff (including doctor, pharmacist, nurse) Subjects engaged in pharmaceuticals and medical devices industry Subjects engaged in pharmaceuticals distributor Subjects engaged in information provision service , research and advertisement industry Subjects with severe allergic conjunctivitis (vernal keratoconjunctivitis , atopic keratoconjunctivitis )

Design outcomes

Primary

MeasureTime frame
Relationship between drug adherence status and background of Patients Effect of treatment satisfaction and QOL with ophthalmic solutions adherence status—

Countries

Japan

Contacts

Public ContactNaomi Otsuka

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs, Development Management Department, Japan Business

clinical@santen.co.jp06-4802-9603

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026